Chronotropic Incompetence During Exercise Testing in Obese Adolescents
NCT ID: NCT04185753
Last Updated: 2019-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2019-11-29
2020-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
During CPET, mechanical constraints in ventilation, an elevated risk for hypoxia and chronotropic incompetence (CI) (defined as the inability of the heart to increase its rate with increased activity), or compromised cardiac function (e.g. lowered heart rate (HR) recovery, chronotropic index and stroke volume) are often observed in obese adults. Moreover, several studies regarding exercise capacity and cardiopulmonary responses to maximal endurance exercise testing have been performed in obese adolescents. Despite these previous investigations in obese adolescents it remains controversial whether cardiopulmonary disturbances can be observed consistently during CPET. However, a number of studies have reported a suboptimal response to exercise, in particular a reduced peak heart rate (HRpeak) and peak cycling power output (Wpeak). Adult obesity modifies cardiac behavior, including resting HR and CI, which has a marked effect on exercise capacity. Therefore, chronotropic variables are the most important factors that affect exercise performance. It has been shown that both peak and resting HR account for over forty percent of variability of exercise capacity. Interestingly, resting HR and HR response to exercise, including a blunted HR increase, low chronotropic index and HR recovery, are important predictors of all-cause mortality and cardiovascular death, at least in adults. These changes in HR during and recovery from CPET are mediated by the balance between sympathetic and vagal activity of the autonomic nervous system. Adverse cardiovascular outcomes associated with the metabolic syndrome may be mediated by autonomic dysfunction, whereby obesity is characterized by sympathetic predominance and a decrease in vagal activity in the basal state, where reduced sympathetic responsiveness has been observed during exercise. Therefore, these multiple exercise risk markers could provide valuable clinical information regarding cardiometabolic health. Nonetheless HR behavior during CPET has not been described in obese adolescents. The goal of this study is to examine the HR behavior of obese adolescents during CPET to clarify whether this population suffer from CI.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial
NCT01040429
Physiological Response to Salbutamol and Exercise
NCT03902106
Influence of Bedrest and Hypocaloric Nutrition on Endothelium-Dependent Vasoreactivity
NCT00175968
Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity
NCT06978777
Effects of Phenylephrine on Cardiac Preload
NCT02739399
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese adolescents with CI
Obese adolescents with chronotropic incompetence
The prevalence of chronotropic incompetence during maximal cardiopulmonary exercise testing
The prevalence of chronotropic incompetence during maximal cardiopulmonary exercise testing
Control group
Obese adolescents without chronotropic incompetence
The prevalence of chronotropic incompetence during maximal cardiopulmonary exercise testing
The prevalence of chronotropic incompetence during maximal cardiopulmonary exercise testing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The prevalence of chronotropic incompetence during maximal cardiopulmonary exercise testing
The prevalence of chronotropic incompetence during maximal cardiopulmonary exercise testing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parental permission
Exclusion Criteria
* Medication use that could possibly influence the heart rate
11 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hasselt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dominique Hansen
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dominique Hansen, PhD
Role: PRINCIPAL_INVESTIGATOR
Hasselt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virga Jesse hospital - Heart centre Hasselt
Hasselt, Limburg, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIDCET study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.